Objective: Better prediction of tissue prognosis in acute stroke might improve treatment decisions. We hypothesized that there are metabolic ischemic disturbances measurable noninvasively by proton magnetic resonance spectroscopy ( 1 H MRS) that occur earlier than any structural changes visible on diffusion-tensor imaging (DTI), which may therefore serve for territorial identification of tissue at risk.
In clinical stroke practice, management decisions, including use of thrombolytic treatment, are based on physical examination, neuroimaging to exclude hemorrhage, and time from stroke onset to treatment, assuming that there is tissue at risk of infarction that could be salvaged. However, for some patients, very early time windows are already too late, while others may have salvageable tissue for many hours after stroke, making the time window alone too nonspecific. 1, 2 Currently there is no reliable, sensitive, and specific method for early noninvasive determination of tissue at risk: the mismatch between diffusion-and perfusion-weighted imaging is still being evaluated, [1] [2] [3] [4] and there are no CSF or blood markers that diagnose stroke or predict prognosis reliably. 5, 6 We hypothesized that in acute ischemic stroke, metabolic disturbances could be measurable in ischemic tissue much earlier than any structural changes. If true, changes in brain metabolite concentrations in normalappearing tissue on diffusion imaging outside the lesion soon after ischemic stroke measured with magnetic resonance spectroscopy (MRS) 7, 8 might predict the likelihood and direction of further infarct expansion and hence prognosis. To test this hypothesis, we compared concentrations of selected brain metabolites measured with MRS in the normal-appearing tissue around the acute infarct as seen on diffusion-tensor imaging (DTI) early after stroke that converted to infarction by 3 to 7 days with that which remained normal on DTI. The selection of metabolites for this study was based on the assumptions that they should represent important elements in pathophysiologic pathways following acute stroke and that their concentrations are readily observable in a short scanning time.
METHODS Patient recruitment. We prospectively recruited patients with acute ischemic stroke and without contraindications to MRI admitted to our hospital acute stroke service. Each patient was carefully examined by a stroke physician who measured stroke severity using NIH Stroke Scale (NIHSS) and determined stroke subtype by the Oxfordshire Community Stroke Project (OCSP) classification. 9 Patients underwent MRI as soon as possible after stroke but within a maximum of 24 hours from onset. Follow-up MRI was performed at 3 to 7 days after stroke. Onset was defined as the time when signs were first noticed by a patient, or symptoms first observed, or, if a patient awoke already having stroke symptoms, the time last known to be well.
Standard protocol approvals, registrations, and patient consents. The study was approved by the Lothian Research Ethics Committee on human experimentation and written informed consent was obtained from the patients or assent from their relatives.
Diffusion and spectroscopy techniques. All magnetic resonance data were obtained on a GE Signa HDX 1.5 T (General Electric, Milwaukee, WI) scanner with self-shielding gradients (33 mT/m maximum) and a birdcage quadrature head coil. In each patient, we performed axial T2-weighted fast spin-echo and fluid-attenuated inversion recovery (FLAIR) imaging, axial diffusion-weighted imaging (DWI), and/or DTI with field of view (FOV) 240 ϫ 240 mm, 15 axial slices of thickness 5 mm, slice gap 1 mm, acquisition matrix 128 ϫ 128, echo time 97.4 msec, repetition time 10 s, and diffusion sensitizing gradients with scalar b-values of 1,000 s/mm 2 applied in 6 noncollinear directions, and multivoxel point resolved spectroscopy (PRESS)localized proton MRS ( 1 H MRS, FOV 320 ϫ 320 mm, slice thickness 10 mm, acquisition matrix 24 ϫ 24, echo time 145 msec, repetition time 1,000 msec). DTI and 1 H MRS with FLAIR and T2* imaging were performed on admission, and DTI, FLAIR, and T2* at 3-7 days after stroke. The 1 H MRS voxel grid was carefully centered on the slice showing the maximum ischemic lesion extent on DTI (figures 1 and 2) and placed within brain to avoid contamination of the spectra by lipid signal from bone marrow or subcutaneous tissue, but to include as much of the brain as possible. We used the scanner's standard 3-pulse chemical shift selective water suppression and shimming, optimized on the slice of interest. Additional saturation bands were placed around the PRESS box to minimize lipid contamination. Each 1 H MRS dataset took approximately 9 minutes to acquire, and the data were effectively "averaged" over this period. Bulk patient motion and eddy current-induced artifacts were removed from the DTI data using a 3-dimensional computational image alignment program to register the component echoplanar imaging volumes to the T2-weighted volumes acquired with the DTI protocol. Maps of the average DTI signal were obtained from the 6 DTI images acquired for each slice.
Spectroscopic images were interpolated to a 32 ϫ 32 matrix yielding 1,000 mm 3 voxels and all processing was carried out on a voxel-by-voxel basis after setting the residual water signal in each voxel to a standard chemical shift of 4.70 ppm. All spectroscopic data were modeled in the time domain by 5 Gaussian components (corresponding to choline, creatine, N-acetylaspartate [NAA], and the lactate doublet) using the Advanced Method for Accurate Robust and Efficient Spectral Fitting algorithm within the Magnetic Resonance User Interface package (http://www.mrui.uab.es/mrui). The data were transformed to spectra for display and visual quality control purposes.
Metabolite concentrations. Choline, creatine, NAA, and lactate were identified by their characteristic appearances at echo time 145 msec (figure 1). Metabolite quantification took into account coil loading (using the scanner's radiofrequency trans-
Figure 1
Sample spectra
Examples of 1 H magnetic resonance spectroscopy spectra from different brain regions defined on diffusion-tensor imaging of an acute ischemic stroke patient: lesion core (0400), infarct expansion area (0398), contralateral normal tissue (0561 and 0622).
mitter gain) and receiver gain thus enabling intersubject (and obviously intrasubject) comparison of individual metabolite concentrations. Careful patient setup ensured between-subject setup reproducibility and good coil uniformity: we previously found that coil uniformity is very good across an axial slice near the center of the coil (data not published). Our metabolite concentration unit was an international unit (IU).
Tissue classification and estimation of tissue metabolite concentrations. 1 H MRS and DTI data were coregistered
using an affine transformation. The multivoxel MRS grid was superimposed onto the admission DTI using software designed inhouse. The grid voxels on admission DTI were classified as falling on or outside the acute DTI hyperintense ischemic lesion blind to all other information; then the voxel grid was compared with the DTI lesion appearance at 3-7 days to identify voxels superimposed on tissue located outside the lesion that were normal on admission and remained normal on follow-up, or voxels superimposed on tissue located outside the lesion that were normal on admission but became hyperintense on DTI at 3-7 days, also blind to all other data. We used the diffusion image at 3-7 days as an indication of infarct growth because at 3-7 days diffusion imaging usually mirrors the 3-7 day T2 or FLAIR appearance, 10 and is easier to assess visually than the B0-T2 image. Although the 3-7 day infarct extent is not the final infarct (because infarct evolution is generally considered to be complete by 3 months), it is a useful indicator of early lesion growth due to recruitment of early penumbral tissue into the infarct before other secondary events can influence infarct extent (e.g., recurrent stroke, hypotension).
Figure 2 Tissue categorization on diffusion-tensor imaging (DTI)
Example of spectroscopy voxel categories according to the appearance of the brain on DTI and the changes of its appearance on the follow-up DTI. The voxel grid numbering on the follow-up is not consistent with the one on the admission image.
The concentrations of choline, creatine, NAA, and lactate from each voxel in the spectroscopy grid were extracted and compared between 1) voxels on the admission DTI that appeared normal around the ischemic lesion, but that converted to infarction on the follow-up DTI (infarct expansion voxels); and 2) voxels on the admission DTI that appeared normal around the ischemic lesion, which remained "healthy" on the follow-up DTI (nonexpansion voxels).
Additionally, each infarct expansion voxel was classified as either complete infarct expansion voxel (infarcted tissue on the follow-up DTI covered over 50% of each individual voxel) or partial infarct expansion voxel (infarcted tissue on the follow-up DTI covered less than 50% of each individual voxel) (figure 2). The subdivision was introduced to investigate whether the metabolite concentration measured early after stroke in periinfarcted tissue can be used for estimating the magnitude of potential infarct expansion (quantitative analysis) in addition to making prognosis on infarct expansion on a yes or no basis.
Statistical analysis.
We compared choline, creatine, NAA, and lactate concentrations in nonexpansion and expansion voxels using a linear mixed model. We tested the change in metabolite concentrations per change in expansion category: from nonexpansion, via partial expansion (below 50% of each voxel), to complete expansion (over 50% of each voxel). We used the logarithmic transformations (log) of the metabolite concentrations rather than their raw values because the model fitted better when metabolite concentrations were linear.
RESULTS
We recruited 31 patients (mean age 74 years; range 45-88) with acute ischemic stroke between December 2007 and March 2009 with admission and follow-up imaging. According to OCSP classification, 9 there were 11 total anterior circulation strokes, 12 partial anterior circulation strokes, 5 lacunar strokes, 2 posterior circulation strokes, and 1 undetermined subtype. The mean NIHSS was 10, median 7, range 0 -28. The mean time from stroke onset to admission MRI was 16.3 hours, median 17 hours, range 4 -26 hours. Four patients underwent initial MRI by 2 hours beyond the designed 24 hours but were included in the analysis (decision taken blind to any information on the results) as the benefits (more reliable statistics in a larger cohort) outweighed the drawbacks. We identified 108 nonexpansion voxels and 113 expansion voxels among which there were 80 complete expansion voxels and 33 partial expansion voxels. Amid 31 patients there were 27 with at least 1 nonexpansion voxel and 20 with 1 or more expansion voxels. Among 5 patients classified with lacunar stroke on admission, definite lesion growth was observed in 3 using our voxel classification.
Choline. Mean brain choline concentration in healthy-looking voxels on initial DTI that converted to infarction on the follow-up DTI (expansion voxels) was higher than in DTI tissues immediately outside the lesion which remained healthy-looking on the follow-up DTI (nonexpansion voxels; figure 3) ; the log of the choline concentration increased by 0.48 units (95% confidence interval 0.0069 -0.95) for each change in expansion category from the baseline of nonexpansion, through partial, to complete expansion ( p ϭ 0.047; figure 3 ).
Lactate. Although lactate concentration was highest in complete expansion voxels and lowest in nonexpansion voxels (complete expansion 1,078; partial expansion 962; nonexpansion 654 IU), the change in tissue lactate concentration with expansion category was not significant (figure 4).
N-acetylaspartate.
There was no difference in NAA concentration in expansion vs nonexpansion voxels ( p ϭ 0.60; figure 4 ).
Creatine. There was no difference in creatine concentration in expansion vs nonexpansion voxels ( p ϭ 0.13; figure 4 ). DISCUSSION We found that choline concentration measured by 1 H MRS in DTI normal-appearing tissue located around the ischemic lesion within the first 26 hours from stroke onset was elevated in those voxels that became infarcted on DTI within the next few days. Moreover, the degree of ischemic expansion was associated with the degree of elevation of choline concentration. Further studies are required to determine whether choline concentration is a reliable, sensitive, or specific measure for predicting infarct growth, including identification of the potential threshold values, and therefore could be used to support treatment decisions in routine practice.
We speculated that metabolite concentrations might have prognostic value because some metabolic products are pathophysiologically likely to mirror cellular sufficiency/insufficiency at the time of imaging. This is in contrast to other approaches to detect tissue at risk, for example perfusion imaging (including DWI/PWI mismatch), which gives an indirect estimate of tissue state by extrapolating from blood flow levels. 11, 12 Hypothetically, in ischemic stroke patients, thrombolytic treatment might be considered over 6 hours from onset if there was still a high probability of further lesion expansion and if this could be assessed reliably and noninvasively on admission. However, as this is only speculative at this stage, further studies are required involving prospective 1 H MRS metabolite measurement in acute ischemic stroke with clinical characteristics, ideally in patients treated with tissue plasminogen activator. Importantly, the time needed to obtain 1 H MRS data seems acceptable in the clinical setting as it takes no longer than 10 minutes (much less in some circumstances). Although currently our approach demands specialist offline image processing, all magnetic resonance manufacturers now provide MRS processing software on console, which could be used in routine practice, enabling results to be obtained within a reasonable time after MRI.
Several previous studies assessed metabolite concentrations measured by MRS to predict final infarct size, clinical deficit, or functional outcome. [11] [12] [13] [14] [15] [16] However, with few exceptions, 11, 12, 16 they mainly focused on metabolites measured within the lesion core. In our study, we prospectively investigated associations between metabolic disturbances in anatomically normal periinfarct tissue (on DTI) and future qualitative and quantitative ischemic changes on DTI in the same tissue. This approach might allow determination of the anatomic direction of lesion expansion, estimate prognosis for a particular brain region, or possibly predict the magni-tude of future ischemic changes (partial or complete expansion).
We selected lactate, NAA, choline, and creatine because their concentrations are readily observable in a relatively short scanning time using a widely available MRS technique. The short scanning time is important in managing severely ill stroke patients as it does not significantly delay interventions in clinical practice. 7, 8 Concentrations of other metabolites measurable with longer scanning sessions (such as glutamate) might be of support in estimating penumbra but are currently much more difficult to measure reliably in clinical practice, although their utility for this approach should be also investigated in the future.
Previous studies on choline pathophysiology in the brain showed that mild hypoxia significantly increased cerebral choline levels 17 and its concentration decreased within days of ischemia-induced membrane rupture. 18 The effect of mild hypoxia would be consistent with choline concentration being highest in the tissue which became infarcted, as in our results, although it is unlikely that membrane rupture would fit with our results as this is usually a late occurrence in established infarction when the lesion would be clearly visible on DTI, not in normalappearing tissue. The hypotheses that might explain our finding of elevated choline and progression of penumbral tissue to infarction include upregulation of genes for enzymes responsible for metabolism of free choline, phosphatidylcholine (a compound containing 95% of the total pool of body choline), phosphocholine or CDP-choline (intermediates toward phosphatidylcholine synthesis), such as CTP:phosphocholine cytidylyltransferase, or body choline redistribution for the benefit of the ischemic brain. 19
Figure 4 Metabolites and lesion expansion
Brain concentration of metabolites (mean of patients' means shown) in infarct nonexpansion (gray columns) vs infarct expansion (green columns) voxels (differences were not significant for lactate, N-acetylaspartate, and creatine).
These mechanisms might stimulate and enable neurite branching or stabilization of neurolemma, and thus promote tissue salvage. 19 Alternatively, patients whose ischemic lesion grew might have had lower brain choline concentrations before stroke, and therefore their brains' cells were prone to quicker membrane destabilization and thus to infarction. We recently showed that choline is not a "stable" metabolite in acute stroke lesions, but changes with time after stroke. 20 This questioned the commonly regarded potential of choline to serve as a denominator for other metabolite concentration measurements, which may perhaps be the main reason for missing it as a marker of tissue at risk of infarction in its own right. Future studies are needed to explain the pathophysiologic background of elevated choline concentration early after acute ischemia prior to any structural changes in the brain on DTI.
The increase in lactate concentration is the net effect of its overproduction, impaired utilization, and decreased washout in ischemic brain and might correlate with oxygen deprivation. 8, 12, [21] [22] [23] [24] In stroke patients, lactate concentration is the highest in the lesion core, and then in the penumbral tissue as defined by DWI/PWI mismatch 11, 12 or in a rim of normal tissue on DTI immediately outside the lesion. 8 In previous studies 11, 12 lactate correlated with the apparent diffusion coefficient and perfusion values but not NAA, thus confirming that all of these measures are markers of the presence of ischemia though not necessarily of tissue fate. In our cohort, brain lactate concentration increased from nonexpansion through partial expansion to complete expansion tissue but the differences were not significant. Therefore a larger study is needed to properly assess the role of lactate in prediction of future infarction.
NAA, a compound nearly exclusively localized in adult neurons, decreases in ischemic stroke, the level of reduction being related to the severity of ischemia. 12, 14, [25] [26] [27] [28] [29] [30] It is considered as a marker of neuronal death but also of tissue dysfunction. 26, 27 However, in agreement with previous studies, 12 we found that NAA concentration did not identify active penumbra in acute stroke. This is explainable physiologically because our metabolite measurements were performed when all analyzed tissues were radiologically normal on DTI, prior to neuronal death. These results are also consistent with previous findings showing that although NAA was decreased in the lesion core, its concentration remained normal outside the visible infarct in penumbral tissue. 11, 12, 16, 25, [28] [29] [30] We had hypothesized that decreased brain concentrations of creatine might be associated with conversion to infarction because creatine inhibits caspase-mediated neuronal death. 31, 32 However, we did not find that 1 H MRS-measured creatine concentrations identified tissue at risk, which might also question its putative neuroprotective role. 31, 32 This study has several limitations. We were only able to recruit and repeat imaging on 31 subjects, a relatively small patient cohort. We have not compared metabolite concentrations with cerebral perfusion data, which might be helpful to explain the pathophysiologic background for some of our results. For example, elevated lactate in normal-appearing voxels immediately outside the infarct would be consistent with a perfusion deficit (i.e., DWI/PWI mismatch) as in previous studies. 12, 14 We compared the images from different timepoints voxel-by-voxel manually, a time-consuming and demanding procedure, and in some patients we did not manage to obtain identical admission and follow-up brain sections. Future developments might automate this procedure to better compensate for differences in head placement and image location between visits. We did not divide patients according to the time from stroke onset to imaging, and this may have influenced the results as tissue biochemical processes are much more dynamic than changes in structure. However, any subdivision of a 31-subject cohort would not produce reliable statistics. Additionally, the method for determining tissue at risk should be usable at any time from stroke onset. On the other hand, there might be different ranges of brain metabolite concentrations indicating the likelihood of conversion to infarction at different time points from stroke. Finally, the in vivo 1 H MRS has several physical limitations, as listed and discussed in detail previously. 8 and receives research support from the Stroke Association, the Row Fogo Trust, the Medical Research Council (UK), the Wellcome Trust, the Translational Medicine Research Collaboration, Age UK, and the Scottish Funding Council.
